Literature DB >> 10480359

Prevalence of germline mutations of hMLH1, hMSH2, hPMS1, hPMS2, and hMSH6 genes in 75 French kindreds with nonpolyposis colorectal cancer.

Q Wang1, C Lasset, F Desseigne, J C Saurin, C Maugard, C Navarro, E Ruano, L Descos, V Trillet-Lenoir, J F Bosset, A Puisieux.   

Abstract

Hereditary nonpolyposis colorectal cancer (HNPCC) is a syndrome characterized by familial predisposition to colorectal carcinoma and extracolonic cancers of the gastrointestinal, urological, and female reproductive tracts. This dominant disorder is caused by germline defects in one of at least five DNA mismatch repair (MMR) genes: hMLH1, hMSH2, hPMS1, hPMS2, and hMSH6 (GTBP). Germline mutations of hMSH2 and hMLH1 are also frequently identified in families not fulfilling all the Amsterdam criteria, thereby demonstrating that the involvement of these genes is not confined to typical HNPCC. To evaluate the respective involvement of the various MMR genes in typical and incomplete HNPCC syndromes, we have performed an analysis of the hMLH1, hMSH2, hPMS1, hPMS2, and hMSH6 genes in a large series of French kindreds (n=75) with colorectal tumors and/or aggregation of extracolonic cancers belonging to the HNPCC spectrum. Mutational analysis has been performed in all families, without preselection for the tumor phenotype. We have detected 26 pathogenic germline mutations of the hMLH1 and hMSH2 genes and several novel variants of the hPMS1, hPMS2, and hMSH6 genes. Our data confirm that, regardless of the type of families and the tumor phenotype, hPMS1, hPMS2, and hMSH6 germline mutations are rare in familial aggregation of colorectal cancers. Furthermore, they suggest that the presence of multiple primary malignancies in a single individual and the observation of extracolonic tumors in relatives of a colorectal cancer patient should be included among the guidelines for referring patients for genetic testing.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10480359     DOI: 10.1007/s004399900064

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  40 in total

1.  Identification of mismatch repair gene mutations in young patients with colorectal cancer and in patients with multiple tumours associated with hereditary non-polyposis colorectal cancer.

Authors:  R C Niessen; M J W Berends; Y Wu; R H Sijmons; H Hollema; M J L Ligtenberg; H E K de Walle; E G E de Vries; A Karrenbeld; C H C M Buys; A G J van der Zee; R M W Hofstra; J H Kleibeuker
Journal:  Gut       Date:  2006-04-24       Impact factor: 23.059

2.  Regulation of the human MSH6 gene by the Sp1 transcription factor and alteration of promoter activity and expression by polymorphisms.

Authors:  Isabella Gazzoli; Richard D Kolodner
Journal:  Mol Cell Biol       Date:  2003-11       Impact factor: 4.272

3.  Pattern of sequence variation across 213 environmental response genes.

Authors:  Robert J Livingston; Andrew von Niederhausern; Anil G Jegga; Dana C Crawford; Christopher S Carlson; Mark J Rieder; Sivakumar Gowrisankar; Bruce J Aronow; Robert B Weiss; Deborah A Nickerson
Journal:  Genome Res       Date:  2004-09-13       Impact factor: 9.043

Review 4.  Clinical correlation and molecular evaluation confirm that the MLH1 p.Arg182Gly (c.544A>G) mutation is pathogenic and causes Lynch syndrome.

Authors:  Michael P Farrell; David J Hughes; Ian R Berry; David J Gallagher; Emily A Glogowski; Stewart J Payne; Michael J Kennedy; Róisín M Clarke; Susan A White; Cian B Muldoon; Fiona Macdonald; Pauline Rehal; Danielle Crompton; Solvig Roring; Sarah T Duke; Trudi McDevitt; David E Barton; Shirley V Hodgson; Andrew J Green; Peter A Daly
Journal:  Fam Cancer       Date:  2012-09       Impact factor: 2.375

5.  Inactivation of DNA mismatch repair by variants of uncertain significance in the PMS2 gene.

Authors:  Mark Drost; Hester Koppejan; Niels de Wind
Journal:  Hum Mutat       Date:  2013-09-11       Impact factor: 4.878

6.  MLH1 and MSH2 mutations in Colombian families with hereditary nonpolyposis colorectal cancer (Lynch syndrome)--description of four novel mutations.

Authors:  Alejandro Giraldo; Andrea Gómez; Gustavo Salguero; Herbert García; Fabio Aristizábal; Oscar Gutiérrez; Luis Alberto Angel; Jorge Padrón; Carlos Martínez; Humberto Martínez; Omar Malaver; Luis Flórez; Rosa Barvo
Journal:  Fam Cancer       Date:  2005       Impact factor: 2.375

7.  Mutational analysis of hMsh6 in Israeli HNPCC and HNPCC-like families.

Authors:  Shiri Dovrat; Arie Figer; Herma H Fidder; Pavlos Neophytou; Zvi Fireman; Ravit Geva; Jamal Zidan; Dov Flex; Shimon Bar Meir; Eitan Friedman
Journal:  Fam Cancer       Date:  2005       Impact factor: 2.375

8.  Some aspects of molecular diagnostics in Lynch syndrome.

Authors:  Grzegorz Kurzawski
Journal:  Hered Cancer Clin Pract       Date:  2006-12-15       Impact factor: 2.857

9.  Jungermannenone A and B induce ROS- and cell cycle-dependent apoptosis in prostate cancer cells in vitro.

Authors:  Yan-Xia Guo; Zhao-Min Lin; Mei-Juan Wang; Yi-Wen Dong; Huan-Min Niu; Charles Yf Young; Hong-Xiang Lou; Hui-Qing Yuan
Journal:  Acta Pharmacol Sin       Date:  2016-05-02       Impact factor: 6.150

10.  Investigation on the role of nsSNPs in HNPCC genes--a bioinformatics approach.

Authors:  C George Priya Doss; Rao Sethumadhavan
Journal:  J Biomed Sci       Date:  2009-04-24       Impact factor: 8.410

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.